Is polysomnography feasible and useful for hospitalized patients? Source: Eur Respir J 2004; 24: Suppl. 48, 571s Year: 2004
Microalbuminuria as a potential novel cardiovascular biomarker in patients with COPD Source: Eur Respir J 2014; 43: 951-953 Year: 2014
NT-pro BNP is a marker for cardiovascular dysfunction due to obstructive sleep apnea syndrome Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease Year: 2010
Is spirometry screening useful for detecting undiagnosed COPD? Source: Annual Congress 2011 - Respiratory epidemiology: methods, definitions and phenotypes Year: 2011
Combination of prognostic tools for identifying high-risk normotensive patients with acute symptomatic pulmonary embolism Source: Annual Congress 2010 - Pulmonary embolism Year: 2010
Evaluation of a new cardiac arrhythmias predictor in patients with COPD Source: International Congress 2018 – Cardiovascular morbidities in COPD Year: 2018
High-sensitive troponin T as a new biomarker and an indicator of disease severity in patients with pulmonary arterial hypertension Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension Year: 2008
Usefulness of GDF-15 as a biomarker of respiratory worsening in COVID-19 patients. Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021
Screening for SDB in cardiac patients in the acute and ambulatory setting Source: ERS Conference Year: 2015
Relationship between NT-proBNP level, echocardiographic parameters and cardiovascular diseases in patients with obstructive sleep apnoea (OSA) Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA Year: 2012
The diagnostic value of self-reported symptoms for the detection of sleep apnea syndrome in stroke patients Source: Annual Congress 2012 - Technology, screening and questionnaires in OSA Year: 2012
Combined utility of brain natriuretic peptide and cardiac troponine I may improve rapid triage and risk stratification in patients with pulmonary embolism Source: Eur Respir J 2005; 26: Suppl. 49, 271s Year: 2005
Prevalence of echocardiographic disturbances in SAHS patients. Relationship to disease severity Source: Annual Congress 2007 - Systemic effects of obstructive sleep apnoea Year: 2007
Predictive value of multiorgan imaging biomarkers for predicting exacerbations in COPD patients Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018
Is diaphragmatic thickness fraction valuable in identifying high-risk chronic obstructive pulmonary disease patients? Source: International Congress 2017 – What is new in COPD diagnosis and classification? Year: 2017
Clinical phenotyping of COPD patients: a simple tool with prognosis value Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018
Clinical and prognostic value of atrial natriutic peptide in patients with idiopathic pulmonary hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 659s Year: 2006
Prevalence and underdiagnosis of COPD in patients with ischemic heart disease demonstrated by coronary angiography. Prognostic implications Source: International Congress 2015 – COPD: notable points Year: 2015
Gerd questionnaire as a tool for diagnosing GERD in patients with chronic obstructive pulmonary disease. Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases Year: 2020
A point-of-care brain natriuretic peptide assay in the risk stratification and management of patients with pulmonary arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 48s Year: 2006